Genmeds Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 160.38%
- Profit Growth 25.47%
- Ebitda 28.72%
- Net Worth 22.55%
- Total Assets 8.55%
About Genmeds
Genmeds Private Limited (GPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 December 2017 (Seven years and two months 2 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sajjadali Syed and Riyastali Syed serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909MH2017PTC302759
-
Company No.
302759
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Dec 2017
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Genmeds?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sajjadali Syed
|
Director | 12-Dec-2017 | Current |
|
Riyastali Syed
|
Director | 12-Dec-2017 | Current |
Financial Performance of Genmeds.
Genmeds Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 160.38% increase. The company also saw a substantial improvement in profitability, with a 25.47% increase in profit. The company's net worth Soared by an impressive increase of 22.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genmeds?
In 2020, Genmeds had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Biovion Pharma Private LimitedSajjadali Syed is a mutual person
-
Amyntas Pharma Private Limited
Sajjadali Syed is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genmeds?
Unlock and access historical data on people associated with Genmeds, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genmeds, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genmeds's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.